Assertio Holdings, Inc

Short Term Long Term Short Term Comparison Long Term Comparison
  • ASRT
  • 1d-1.95%
  • 1w-2.18%
  • 1m-6.28%
  • 1y58.04%
ATH
  • ATH Price$133.12
  • ATH Date2015-07-21
  • % since ATH-96.97%
  • % to ATH3,203.23%
ATL
  • ATL Price$0.86
  • ATL Date2021-10-06
  • % from ATL368.60%
  • Last Low Price$0.86
  • Last Low Date2021-10-06
  • % From Last Low368.60%
IPO
  • IPO Price$4.00
  • % Current ROI USD100.75%
  • ATH Price$133.12
  • % ROI ATH 1,547,906.98%
Share

Graph takes few seconds to load...

Key Data
Share

Current price $4.03
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Today's High/Low $4.21/$4.02
Volume 696,868.00
Previous Close $4.11
52 Week High/Low $4.44/$1.86
Market Cap 198,486,704.00
P/E Ratio 7.7547
Forward P/E 1 Yr. $6.15
Earnings Per Share(EPS) $0.5
Annualized Dividend $0
$4.03
Share

Assertio Holdings, Inc., a commercial pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation.
The company’s pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; moderate to severe ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis.
It also provides CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for the treatment of migraine, nausea, photophobia, and phonophobia; Zipsor, an NSAID for relief of mild to moderate acute pain; and SPRIX, an NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level.
The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 1995 and is headquartered in Lake Forest, Illinois.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity